InvestSMART

Atlas Arteria (ASX: ALX) - Announcements

- Current share price for ALX : $3.700

ASX company news and announcements for Atlas Arteria (ALX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Atlas Arteria (ALX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Atlas Arteria (ALX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Atlas Arteria (ALX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$5,378 Notice of Status of Defeating Conditions 18 Jun 2026 12:31PM $5.105 $3.700 fallen by 27.52%
$5,378 Release of Fourth Supplementary Target's Statement 18 Jun 2026 9:14AM $5.100 $3.700 fallen by 27.45%
$5,378 Eighth Supplementary Bidder's Statement 17 Jun 2026 12:45PM $5.110 $3.700 fallen by 27.59%
$5,378 Release of Third Supplementary Target's Statement 16 Jun 2026 9:14AM $5.110 $3.700 fallen by 27.59%
$5,378 Change in substantial holding - IFM 16 Jun 2026 8:21AM $5.110 $3.700 fallen by 27.59%
$5,378 IFM's Seventh Supplementary Bidder's Statement 15 Jun 2026 11:03AM $5.105 $3.700 fallen by 27.52%
$5,378 Seventh Supplementary Bidder's Statement 15 Jun 2026 8:42AM $5.080 $3.700 fallen by 27.17%
$5,378 Sixth Supplementary Bidder's Statement 10 Jun 2026 5:18PM $5.080 $3.700 fallen by 27.17%
$5,378 Fifth Supplementary Bidder's Statement 9 Jun 2026 9:11AM $5.070 $3.700 fallen by 27.02%
$5,378 Release of Second Supplementary Target's Statement 5 Jun 2026 9:05AM $5.070 $3.700 fallen by 27.02%
$5,378 Fourth Supplementary Bidder's Statement 3 Jun 2026 4:53PM $5.060 $3.700 fallen by 26.88%
$5,378 Release of Supplementary Target's Statement 2 Jun 2026 9:21AM $5.040 $3.700 fallen by 26.59%
$5,378 Third Supplementary Bidder's Statement 1 Jun 2026 9:51AM $4.930 $3.700 fallen by 24.95%
$5,378 Second Supplementary Bidder's Statement 26 May 2026 12:13PM $4.855 $3.700 fallen by 23.79%
$5,378 Lodgement of Atlas Arteria's Target's Statement 26 May 2026 8:45AM $4.840 $3.700 fallen by 23.55%
$5,378 TOV: ALX - Panel Declines to Conduct Proceedings 25 May 2026 9:47AM $4.860 $3.700 fallen by 23.87%
$5,378 Expiry of Chicago Skyway ROFO 25 May 2026 8:42AM $4.860 $3.700 fallen by 23.87%
$5,378 Change of Director's Interest Notice 22 May 2026 5:02PM $4.860 $3.700 fallen by 23.87%
$5,378 Notification regarding unquoted securities - ALX 22 May 2026 4:59PM $4.860 $3.700 fallen by 23.87%
$5,378 Notification of cessation of securities - ALX 22 May 2026 4:59PM $4.860 $3.700 fallen by 23.87%
$5,378 Application for quotation of securities - ALX 22 May 2026 4:54PM $4.860 $3.700 fallen by 23.87%
$5,378 TOV: ALX - Panel Declines to Make Declaration 21 May 2026 9:29AM $4.810 $3.700 fallen by 23.08%
$5,378 First Supplementary Bidder's Statement 20 May 2026 10:18AM $4.845 $3.700 fallen by 23.63%
$5,378 Results of Meeting 13 May 2026 12:41PM $4.785 $3.700 fallen by 22.68%
$5,378 2026 AGM addresses and proxy voting results 13 May 2026 9:21AM $4.780 $3.700 fallen by 22.59%

51 - 75 of 771 results

Page 3 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.